Annual revenue:
$51.72B+$5.06B(+10.85%)Summary
- As of today (April 12, 2025), NVS annual revenue is $51.72 billion, with the most recent change of +$5.06 billion (+10.85%) on December 31, 2024.
- During the last 3 years, NVS annual revenue has risen by +$7.75 billion (+17.62%).
- NVS annual revenue is now -12.89% below its all-time high of $59.38 billion, reached on December 31, 2011.
Performance
NVS Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$13.56B+$386.00M(+2.93%)Summary
- As of today (April 12, 2025), NVS quarterly revenue is $13.56 billion, with the most recent change of +$386.00 million (+2.93%) on December 31, 2024.
- Over the past year, NVS quarterly revenue has stayed the same.
- NVS quarterly revenue is now -10.35% below its all-time high of $15.12 billion, reached on June 30, 2011.
Performance
NVS Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$51.72B+$1.78B(+3.57%)Summary
- As of today (April 12, 2025), NVS TTM revenue is $51.72 billion, with the most recent change of +$1.78 billion (+3.57%) on December 31, 2024.
- Over the past year, NVS TTM revenue has stayed the same.
- NVS TTM revenue is now -12.89% below its all-time high of $59.38 billion, reached on December 31, 2011.
Performance
NVS TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
NVS Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | 0.0% | 0.0% |
| 3 y3 years | +17.6% | 0.0% | 0.0% |
| 5 y5 years | +6.3% | 0.0% | 0.0% |
NVS Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.0% | at high | +25.7% | at high | +25.2% |
| 5 y | 5-year | at high | +19.0% | at high | +193.5% | -1.3% | +25.2% |
| alltime | all time | -12.9% | +175.7% | -10.3% | +216.9% | -12.9% | +807.9% |
Novartis AG Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $51.72B(+10.8%) | $13.56B(+2.9%) | $51.72B(+3.6%) |
| Sep 2024 | - | $13.17B(+2.3%) | $49.94B(+2.2%) |
| Jun 2024 | - | $12.87B(+6.2%) | $48.86B(+2.4%) |
| Mar 2024 | - | $12.12B(+2.9%) | $47.73B(+2.3%) |
| Dec 2023 | $46.66B(+7.4%) | $11.78B(-2.6%) | $46.66B(+1.8%) |
| Sep 2023 | - | $12.09B(+3.0%) | $45.85B(+2.9%) |
| Jun 2023 | - | $11.74B(+6.3%) | $44.54B(-2.9%) |
| Mar 2023 | - | $11.05B(+0.7%) | $45.88B(-3.7%) |
| Dec 2022 | $43.46B(-1.2%) | $10.97B(+1.7%) | $47.65B(+15.4%) |
| Sep 2022 | - | $10.78B(-17.6%) | $41.30B(-5.9%) |
| Jun 2022 | - | $13.09B(+2.1%) | $43.88B(-0.5%) |
| Mar 2022 | - | $12.81B(+177.4%) | $44.09B(+0.3%) |
| Dec 2021 | $43.97B(-11.9%) | $4.62B(-65.4%) | $43.97B(-16.1%) |
| Sep 2021 | - | $13.37B(+0.5%) | $52.38B(+1.6%) |
| Jun 2021 | - | $13.29B(+4.7%) | $51.56B(+3.4%) |
| Mar 2021 | - | $12.69B(-2.6%) | $49.88B(-0.0%) |
| Dec 2020 | $49.90B(+2.5%) | $13.03B(+3.9%) | $49.90B(+0.6%) |
| Sep 2020 | - | $12.54B(+7.9%) | $49.58B(+0.1%) |
| Jun 2020 | - | $11.62B(-8.5%) | $49.53B(-0.8%) |
| Mar 2020 | - | $12.71B(-0.1%) | $49.93B(+2.6%) |
| Dec 2019 | $48.68B(+5.6%) | $12.72B(+1.9%) | $48.68B(+1.7%) |
| Sep 2019 | - | $12.48B(+3.8%) | $47.86B(+2.3%) |
| Jun 2019 | - | $12.02B(+5.0%) | $46.76B(+0.8%) |
| Mar 2019 | - | $11.46B(-3.7%) | $46.39B(+0.6%) |
| Dec 2018 | $46.10B(+6.2%) | $11.90B(+4.5%) | $46.10B(+13.4%) |
| Sep 2018 | - | $11.39B(-2.3%) | $40.63B(-3.1%) |
| Jun 2018 | - | $11.65B(+4.4%) | $41.94B(-2.0%) |
| Mar 2018 | - | $11.16B(+73.5%) | $42.78B(-1.4%) |
| Dec 2017 | $43.40B(-12.2%) | $6.43B(-49.3%) | $43.40B(-12.5%) |
| Sep 2017 | - | $12.69B(+1.6%) | $49.58B(+0.7%) |
| Jun 2017 | - | $12.49B(+6.0%) | $49.23B(-0.4%) |
| Mar 2017 | - | $11.79B(-6.5%) | $49.41B(-0.1%) |
| Dec 2016 | $49.44B(-1.9%) | $12.61B(+2.1%) | $49.44B(-0.4%) |
| Sep 2016 | - | $12.34B(-2.7%) | $49.63B(-0.3%) |
| Jun 2016 | - | $12.68B(+7.4%) | $49.78B(-0.4%) |
| Mar 2016 | - | $11.81B(-7.8%) | $49.99B(-0.8%) |
| Dec 2015 | $50.39B(-6.1%) | $12.80B(+2.6%) | $50.39B(-1.1%) |
| Sep 2015 | - | $12.48B(-3.2%) | $50.94B(-1.6%) |
| Jun 2015 | - | $12.90B(+5.7%) | $51.75B(-2.0%) |
| Mar 2015 | - | $12.20B(-8.6%) | $52.80B(-1.5%) |
| Dec 2014 | $53.63B(+1.7%) | $13.35B(+0.4%) | $53.63B(-0.5%) |
| Sep 2014 | - | $13.30B(-4.7%) | $53.91B(+0.7%) |
| Jun 2014 | - | $13.95B(+7.0%) | $53.51B(+1.3%) |
| Mar 2014 | - | $13.03B(-4.4%) | $52.84B(-2.2%) |
| Dec 2013 | $52.72B(+1.4%) | $13.63B(+5.6%) | $54.02B(+8.3%) |
| Sep 2013 | - | $12.91B(-2.8%) | $49.87B(-2.2%) |
| Jun 2013 | - | $13.28B(-6.5%) | $51.00B(-2.4%) |
| Mar 2013 | - | $14.21B(+49.9%) | $52.26B(+0.6%) |
| Dec 2012 | $51.97B | $9.48B(-32.5%) | $51.97B(-9.6%) |
| Sep 2012 | - | $14.04B(-3.5%) | $57.49B(-1.7%) |
| Jun 2012 | - | $14.54B(+4.5%) | $58.48B(-1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $13.91B(-7.2%) | $59.07B(-0.5%) |
| Dec 2011 | $59.38B(+15.2%) | $15.00B(-0.3%) | $59.38B(+0.9%) |
| Sep 2011 | - | $15.03B(-0.6%) | $58.84B(+3.9%) |
| Jun 2011 | - | $15.12B(+6.3%) | $56.63B(+6.0%) |
| Mar 2011 | - | $14.22B(-1.7%) | $53.43B(+3.6%) |
| Dec 2010 | $51.56B(+14.3%) | $14.46B(+12.8%) | $51.56B(+2.6%) |
| Sep 2010 | - | $12.82B(+7.5%) | $50.24B(+3.1%) |
| Jun 2010 | - | $11.92B(-3.5%) | $48.71B(+2.5%) |
| Mar 2010 | - | $12.36B(-6.0%) | $47.53B(+5.4%) |
| Dec 2009 | $45.10B(+5.9%) | $13.14B(+16.4%) | $45.10B(+6.6%) |
| Sep 2009 | - | $11.29B(+5.1%) | $42.31B(+0.6%) |
| Jun 2009 | - | $10.74B(+8.2%) | $42.05B(-0.6%) |
| Mar 2009 | - | $9.93B(-4.1%) | $42.29B(-0.7%) |
| Dec 2008 | $42.58B(+9.3%) | $10.35B(-6.2%) | $42.58B(+0.4%) |
| Sep 2008 | - | $11.03B(+0.4%) | $42.41B(+2.9%) |
| Jun 2008 | - | $10.99B(+7.6%) | $41.20B(+4.0%) |
| Mar 2008 | - | $10.22B(+0.4%) | $39.60B(+2.2%) |
| Dec 2007 | $38.95B(+10.9%) | $10.17B(+3.6%) | $38.76B(+1.4%) |
| Sep 2007 | - | $9.82B(+4.4%) | $38.25B(+2.1%) |
| Jun 2007 | - | $9.40B(+0.3%) | $37.45B(+2.4%) |
| Mar 2007 | - | $9.37B(-2.9%) | $36.56B(+3.5%) |
| Dec 2006 | $35.10B(+18.0%) | $9.65B(+7.0%) | $35.34B(+11.6%) |
| Sep 2006 | - | $9.02B(+6.1%) | $31.66B(+1.7%) |
| Jun 2006 | - | $8.51B(+4.4%) | $31.13B(+2.1%) |
| Mar 2006 | - | $8.15B(+36.3%) | $30.49B(+2.7%) |
| Dec 2005 | $29.75B(+9.1%) | $5.98B(-29.6%) | $29.68B(-2.1%) |
| Sep 2005 | - | $8.49B(+7.9%) | $30.31B(+5.0%) |
| Jun 2005 | - | $7.87B(+7.2%) | $28.88B(+3.2%) |
| Mar 2005 | - | $7.34B(+11.1%) | $27.98B(+2.6%) |
| Dec 2004 | $27.28B(+9.4%) | $6.61B(-6.4%) | $27.28B(-0.7%) |
| Sep 2004 | - | $7.06B(+1.2%) | $27.46B(+3.2%) |
| Jun 2004 | - | $6.97B(+5.0%) | $26.62B(+3.0%) |
| Mar 2004 | - | $6.64B(-2.3%) | $25.85B(+3.7%) |
| Dec 2003 | $24.93B(+19.4%) | $6.80B(+9.4%) | $24.93B(+5.3%) |
| Sep 2003 | - | $6.21B(+0.1%) | $23.66B(+5.1%) |
| Jun 2003 | - | $6.20B(+8.4%) | $22.51B(+2.8%) |
| Mar 2003 | - | $5.72B(+3.4%) | $21.91B(+4.1%) |
| Dec 2002 | $20.88B(+11.3%) | $5.53B(+9.3%) | $21.05B(+4.8%) |
| Sep 2002 | - | $5.06B(-9.6%) | $20.08B(-2.5%) |
| Jun 2002 | - | $5.60B(+15.2%) | $20.60B(+6.7%) |
| Mar 2002 | - | $4.86B(+6.4%) | $19.31B(+2.2%) |
| Dec 2001 | $18.76B(-15.4%) | $4.57B(-18.1%) | $18.89B(-8.5%) |
| Sep 2001 | - | $5.58B(+29.3%) | $20.64B(+3.5%) |
| Jun 2001 | - | $4.31B(-2.9%) | $19.95B(+0.2%) |
| Mar 2001 | - | $4.44B(-29.7%) | $19.91B(-5.9%) |
| Dec 2000 | $22.18B(+8.8%) | $6.31B(+29.4%) | $21.17B(+42.5%) |
| Sep 2000 | - | $4.88B(+14.1%) | $14.86B(+48.9%) |
| Jun 2000 | - | $4.28B(-24.9%) | $9.97B(+75.1%) |
| Mar 2000 | - | $5.70B | $5.70B |
| Dec 1999 | $20.39B(-11.5%) | - | - |
| Dec 1998 | $23.04B | - | - |
FAQ
- What is Novartis AG annual revenue?
- What is the all time high annual revenue for Novartis AG?
- What is Novartis AG annual revenue year-on-year change?
- What is Novartis AG quarterly revenue?
- What is the all time high quarterly revenue for Novartis AG?
- What is Novartis AG quarterly revenue year-on-year change?
- What is Novartis AG TTM revenue?
- What is the all time high TTM revenue for Novartis AG?
- What is Novartis AG TTM revenue year-on-year change?
What is Novartis AG annual revenue?
The current annual revenue of NVS is $51.72B
What is the all time high annual revenue for Novartis AG?
Novartis AG all-time high annual revenue is $59.38B
What is Novartis AG annual revenue year-on-year change?
Over the past year, NVS annual revenue has changed by +$5.06B (+10.85%)
What is Novartis AG quarterly revenue?
The current quarterly revenue of NVS is $13.56B
What is the all time high quarterly revenue for Novartis AG?
Novartis AG all-time high quarterly revenue is $15.12B
What is Novartis AG quarterly revenue year-on-year change?
Over the past year, NVS quarterly revenue has changed by $0.00 (0.00%)
What is Novartis AG TTM revenue?
The current TTM revenue of NVS is $51.72B
What is the all time high TTM revenue for Novartis AG?
Novartis AG all-time high TTM revenue is $59.38B
What is Novartis AG TTM revenue year-on-year change?
Over the past year, NVS TTM revenue has changed by $0.00 (0.00%)